ReviewNature medicine2021
Hindsight is 2020? Lessons in global health governance one year into the pandemic.
Review in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- The complexity of addressing equity in COVID-19-related global health governance and population health research priorities in Canada: a multilevel qualitative study.BMC public health · 2024Article
- COVID-19-related global health governance and population health priorities for health equity in G20 countries: a scoping review.International journal for equity in health · 2023Article
- National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics.Globalization and health · 2023Review
- Lessons from COVID-19 must be learned before the next outbreak.Nature medicine · 2023Article
- COVID-19 and the ecological crisis: What do they have in common?Scandinavian journal of public health · 2023Article
- Global COVID-19 Policy Engagement With Scientific Research Information: Altmetric Data Study.Journal of medical Internet research · 2023Article
- The interfaces between One Health and Global Health: A scoping review.One health (Amsterdam, Netherlands) · 2023Article
- Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals.Scientific reports · 2023Article
- Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies.ACS sensors · 2023Article
- Science in One Health: A new journal with a new approach.Science in One Health · 2022Article
- The Advantages of the Zero-COVID-19 Strategy.International journal of environmental research and public health · 2022Review
- Power across the global health landscape: a network analysis of development assistance 1990-2015.Health policy and planning · 2022Article
- Humanitarian inversions: COVID-19 as crisis.Transactions (Institute of British Geographers : 1965) · 2022Article
- Virus blocking textile for SARS-CoV-2 using human body triboelectric energy harvesting.Cell reports. Physical science · 2022Article
- Biomarkers of ageing and frailty may predict COVID-19 severity.Ageing research reviews · 2022Review
- Optimal non-pharmaceutical intervention policy for Covid-19 epidemic via neuroevolution algorithm.Evolution, medicine, and public health · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fourteen months into the SARS-CoV-2 pandemic, we identify key lessons in the global and national responses to the pandemic. The World Health Organization has played a pivotal technical, normative and coordinating role, but has been constrained by its lack of authority over sovereign member states. Many governments also mistakenly attempted to manage COVID-19 like influenza, resulting in repeated lockdowns, high excess morbidity and mortality, and poor economic recovery. Despite the incredible speed of the development and approval of effective and safe vaccines, the emergence of new SARS-CoV-2 variants means that all countries will have to rely on a globally coordinated public health effort for several years to defeat this pandemic.
Indexed as
Identifiers
33723454What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.